Intelligent Bio Solutions (INBS)

A key part of the company’s commercial focus is portable drug screening based on fingerprint sweat. This approach is designed to be hygienic, quick, and less intrusive than urine, blood, or saliva collection. The company’s testing technology screens for recent use of drug classes such as opioids, cocaine, methamphetamines, benzodiazepines, and cannabis. Potential customers include workplaces, drug treatment providers, criminal justice organisations, and other settings where fast screening can support compliance, safety, or monitoring programmes.

Intelligent Bio Solutions reports its activities across geographic regions including the United Kingdom, Asia Pacific, the Americas, and the rest of the world, with the United Kingdom representing its largest revenue contributor. Its investment profile is shaped by adoption of its testing products, regulatory and customer requirements in different markets, and the company’s ability to expand its biosensor technology beyond existing applications. The business sits at the intersection of diagnostics, workplace safety, and portable health technology, where speed, ease of use, and reliability are central to customer demand.